SG Americas Securities, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$1,051
-30.6%
23,163
-14.2%
0.01%
+9.1%
Q2 2023$1,515
+26.6%
26,981
+2.0%
0.01%
-21.4%
Q1 2023$1,197
+7.7%
26,460
-3.2%
0.01%0.0%
Q4 2022$1,111
-99.9%
27,333
+112.9%
0.01%
+40.0%
Q3 2022$839,000
-78.2%
12,840
-79.7%
0.01%
-75.6%
Q2 2022$3,841,000
+1276.7%
63,212
+1321.5%
0.04%
+1950.0%
Q1 2022$279,000
-84.1%
4,447
-80.8%
0.00%
-80.0%
Q4 2021$1,754,000
-78.2%
23,150
-67.8%
0.01%
-73.7%
Q3 2021$8,054,000
-18.1%
71,956
+18.5%
0.04%
-17.4%
Q2 2021$9,830,000
+35.1%
60,722
+1.7%
0.05%
+21.1%
Q1 2021$7,276,000
+786.2%
59,710
+1013.2%
0.04%
+850.0%
Q4 2020$821,000
+42.0%
5,364
-22.3%
0.00%0.0%
Q3 2020$578,000
-6.0%
6,907
-17.5%
0.00%
-20.0%
Q2 2020$615,000
+53.4%
8,371
+27.1%
0.01%
+25.0%
Q4 2019$401,000
-47.1%
6,585
-64.4%
0.00%
-33.3%
Q3 2019$758,00018,5040.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders